Halozyme Therapeutics shares owned by Brookstone Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Brookstone Capital Management
from 13F filings
Historical chart of Brookstone Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Brookstone Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.5M | 61k | 57.24 |
| 2024-06-30 | $3.4M | 62k | 54.75 |
| 2024-03-31 | $2.5M | 62k | 40.68 |
| 2023-12-31 | $2.2M | 60k | 36.96 |
| 2023-09-30 | $2.2M | 60k | 35.80 |
| 2023-06-30 | $2.2M | 60k | 36.62 |
| 2023-03-31 | $2.2M | 60k | 36.00 |
| 2022-12-31 | $3.3M | 60k | 55.48 |
| 2022-09-30 | $2.6M | 60k | 42.60 |
| 2022-06-30 | $3.1M | 60k | 51.79 |
| 2022-03-31 | $2.5M | 60k | 41.39 |
| 2021-12-31 | $2.2M | 60k | 37.29 |
| 2021-09-30 | $2.2M | 60k | 36.89 |
| 2021-06-30 | $2.7M | 60k | 44.90 |
More positions owned by Brookstone Capital Management
View all positions for Brookstone Capital Management